Treatment of Early Glottic cancer with Transoral Laser Microsurgery: An Australian Experience

Navid Ahmadi*, Danielle Stone, Murray Stokan, Hedley Coleman, Gillian Heller, Mark Smith, Faruque Riffat, Akshay Kudpaje, Michael Veness, Carsten E. Palme

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Early laryngeal carcinomas may be treated by transoral laser microsurgery (TLM) or external beam radiotherapy. We review our experience of surgical treatment of laryngeal pre-malignant and malignant lesions over the past 15 years in a high-volume head neck unit.

Methods: A review of a prospective patient database of patients with laryngeal SCC, who were treated with CO2 TLM between 2004 and 2019 was carried out.

Results: 83 patients with a mean age of 67.7 (SD: 10.6) years underwent primary curative TLM for T1a/b SCC. 5-year overall survival was 93.2% (95%CI 86.9–100%), disease free survival was 86.0% (95%CI 78.1–94.6%), locoregional control was 91.2% (95%CI: 85.1–97.7%) and larynx preservation rate of 95.1% at 5 years.

Conclusion: TLM is an excellent treatment modality for T1 early glottic SCC, with excellent locoregional control and disease-free survival. It is minimally invasive, outpatient-based, and cost-effective procedure preserving upper aerodigestive tract dysfunction for all activities of daily living.

Original languageEnglish
Pages (from-to)661-667
Number of pages7
JournalIndian Journal of Otolaryngology and Head and Neck Surgery
Volume75
Issue number2
DOIs
Publication statusPublished - Jun 2023
Externally publishedYes

Keywords

  • Carcinoma, Squamous cell
  • Laryngeal neoplasms
  • Laryngoscopy
  • Laser therapy
  • Radiotherapy
  • Survival analysis

Fingerprint

Dive into the research topics of 'Treatment of Early Glottic cancer with Transoral Laser Microsurgery: An Australian Experience'. Together they form a unique fingerprint.

Cite this